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SMethods: Data on hospitalizations for STEMI from 2000 through 2010 were
extracted from hospital discharge record databases from all hospitals in Lombardia (a
Northern Italy region with high density population). Main outcome measures were in-
hospital mortality and treatment modality by sex. Treatment modalities included
medical therapy alone or an invasive approach, the latter consisting of coronary
angiography alone, percutaneous coronary intervention (PCI), or coronary artery
bypass graft surgery. Multivariable logistic regression was performed to assess the
impact of female sex and of treatment modality on mortality after adjusting for age,
and comorbidities.
Results: A total of 92807 patients with STEMI, 66.4% men and 33.6% women were
enrolled. Women were older than men (mean 75.1 yrs vs 64.1 yrs, p<0.0001) and had
a higher prevalence of chronic renal failure (p<0.001). In-hospital mortality presented
a small decrease from 7.5% in 2000 to 6.3% in 2010 among men, while it remained
higher and substantially constant over time among women (16.4% in 2000, 16.2% in
2010). The use of an invasive approach increased over time in both sexes (from 55%
in 2000 to 91% in 2010 in men and from 36% in 2000 to 70% in 2010 in women). The
use of PCI increased from 32% in 2000 to 82% in 2010 in men; and from 21% in 2000
to 57% in 2010 in women. At multivariable regression, an invasive approach (odds
ratio (OR) 0.23, 95% conﬁdence interval (CI), 0.21-0.25, p<0.001) was associated
with a signiﬁcant reduction in mortality, while female sex was not a predictor of
mortality (OR 0.96, P¼0.18).
Conclusions: In-hospital mortality remains higher in women than in men, although
female sex is not a signiﬁcant predictor of mortality. Despite temporal increases in the
use of an invasive approach, women are more often treated conservatively.
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Background: The risk for recurrent ischemic events following ST-segment elevation
myocardial infarction (STEMI) gradually declines. However, current guidelines
suggest consistent therapy from presentation out to 12 months. We sought to char-
acterize the actuarial daily ischemic risk (ADIR) in the 12 months year after STEMI.
Methods: Ischemic event rates for all 3602 patients enrolled in the prospective
HORIZONS-AMI trial were categorized according to the timing of their occurrence in
three groups: Group 1: during index hospitalization, Group 2: from hospital discharge
to 30 days, and Group 3: from 30 days post hospital discharge to 1 year. Ischemic
events included: All-cause death, cardiovascular (CV) death, non-CV death, re-
infarction (MI), deﬁnite ST and the composite of CV death, MI or deﬁnite ST. The
ADIR for each event was calculated based on the actual patient days of follow-up for
each group.
Results: Highly signiﬁcant reductions in ADIR were observed as patients transitioned
from Group 1 to Groups 2 and 3 respectively (Table). The degree of ADIR reduction
approached or exceeded a full order of magnitude for all events except for non-CV
death. Accordingly, the relative risk for the composite of CV death, MI or deﬁnite ST
was 15.20 (11.39 - 20.27, p<0.0001) for Group 1 vs. Group 2, 6.31 (4.62 - 8.62,
p<0.0001) for Group 2 vs. Group 3 and 95.94 (76.06 - 121.02, p<0.0001) for Group
1 vs. Group 3.
Conclusions: Conclusions: The risk for CV death and recurrent ischemic events
following an index STEMI treated with primary PCI dramatically declines following
hospital discharge out to the ﬁrst 30 days and declines even further between day 30
and one year. These data suggest that a tailored approach to anti-ischemic protection,
with more potent agents administered in the acute and sub-acute phases and less potent
agents (with lower bleeding potential) administered after 30 days, warrants
investigation.Table. Actuarial daily ischemic risk (ADIR) in 3 successive periods after index
hospitalization for STEMI
ENDPOINT Index hospitalization Discharge to 30 Days 30 Days to 1 year
All-cause death 78/21510 (0.3626%) 22/104397 (0.0211%) 59/1220907 (0.0048%)
CV death 71 / 21510 (0.3301%) 17 / 104397 (0.0163%) 29 / 1220907 (0.0024%)
Non-CV
death
7 / 21510 (0.0325%) 5 / 104397 (0.0048%) 30 / 1220907 (0.0025%)
Re-infarction (MI) 44 / 21510 (0.2046%) 27 / 104397 (0.0259%) 84 / 1220907 (0.0069%)
Deﬁnite ST 76 / 21510 (0.3533%) 17 / 104397 (0.0163%) 0 / 1220907 (0.0000%)
CV death + MI +
Deﬁnite ST
191 / 21510 (0.8880%) 61 / 104397 (0.0584%) 113 / 1220907 (0.0093%)
Trend p-values <0.0001 for all endpoints. All pairwise p-values <0.0001, except p¼0.16 for
Group 2 vs. Group 3 non-CV death.
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Background: We sought to analyze in ST-elevation myocardial infarction (STEMI)
patients the impact of rheolytic thrombectomy (RT) in comparison to manual
thrombus aspiration (MTA) on extension of microvascular obstruction (MVO) and
infarct size (IS) as well as on 1-year left ventricular (LV) volumes and ejection fraction
(EF) by cardiac magnetic resonance imaging (MRI).
Methods: Eighty STEMI patients (6 hours from symptom onset) reperfused by
primary angioplasty with routine abciximab therapy were randomly allocated (1:1) to
a RT or MTA. MRI was performed within 10  6 days in 37 patients (19 RT, 18
MTA), and after 1 year in 19 patients (9 RT). IS and MVO were measured 15 min
after gadolinium injection with late enhancement sequences and were analyzed
quantitatively (as percentage of the left ventricular mass –gr/LV mass-) at a core
laboratory blinded to randomization.
Results: Baseline clinical characteristics were similar between the RT and MTA
groups, as well as baseline TIMI thrombus grade (4.47  0.84 vs. 4.67  0.76,
p¼0.453). After thrombectomy, in RT compared with MTA group the thrombus grade
decreased to 1.11  1.04 vs. 2.17  1.29 (P¼0.04), and after infarct artery stenting
TIMI 3 ﬂow was 100% vs. 89% (P¼0.204), and ST-elevation resolution greater than
70% at 60 minutes was 89% vs. 72% (P¼0.198), respectively. RT compared with
MTA group did not reduced signiﬁcantly myocardial IS [12.2% (6.4-22.1) vs. 19.0%
(7-28.5) , P¼0.224] as well as the extent of MVO [0.0% (0.0-0.17) vs. 0.6% (0.0-1.4),
P¼0.117], but a trend towards a lower incidence of MVO was observed (16% vs.
44%, P¼0.056). At 1-year, the IS did not change [RT 13.2% (6.4-22.1) vs. MTA
11.4% (6.5-27.8), P¼0.253] and the recovery (baseline-1-year) of LV EF was not
different in both groups (RT 1.94.5% vs. MTA 1.18.3%, P¼0.626), with
a reduction of LV volumes found only in RT group (EDV: RT -9.315 ml vs. MTA
929.8 ml, P¼.115; ESV: RT -8.515.2 ml vs. MTA 3.120.3 ml, P¼.180,
respectively).
Conclusions: In setting of STEMI, at 1-year RT in comparison to MTA did not reduce
signiﬁcantly the IS. However a more favorable change of LV volumes were found,
likely due to a more effective thrombus removal and a lower incidence of MVO by
RT.
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Background: The optimal revascularization strategy in patients with multivessel and
left main coronary artery disease (MVD, LMD) presenting with non-ST acute coro-
nary syndrome (NSTE-ACS) is undetermined.
Methods: In this multicenter, prospective registry, 4566 patients with non-ST
elevation myocardial infarction (NSTEMI), unstable angina and MVD including LMD
were enrolled. Following angiography, 3033 patients were assigned for stenting
(10.3% DES), whereas 1533 for CABG. The complete follow-up on mortality was
obtained at 3 years.
Results: In the overall population, patients assigned for PCI were younger (64.410
vs. 65.29 p¼0.03), more frequently presented with NSTEMI (32.0 vs. 14.5%;
p¼0.01), cardiogenic shock (1.5 vs. 0.7% p<0.01) history of prior PCI (13.1 vs. 5.5%;
p<0.01) and CABG (10.6 vs. 4.6%, p<0.01). The Euroscore and TIMI risk score
were slightly higher in PCI patients (5.362.3 vs. 5.162.0 and 3.871.0 vs.
3.790.9 respectively, p<0.01). Patients consigned to CABG more often presented
with triple and LMD (82.2 vs. 33.8% and 13.7 vs. 2.4%; p<0.01). Otherwise,
proximal LAD was more often stented (21.5 vs. 11.1%; p<0.01). After adjustment
929 well-matched pairs were selected. Early mortality was lower after PCI prior to
matching (2.1 vs. 3.1%; p<0.01), whereas after balancing, no difference was found
(2.5 vs. 2.8%; p¼0.62). Three year survival was in favor of PCI when compared to
surgery prior (87.5 vs. 82.8%, HR: 1.44, 95%CI: 1.2-1.7) and after matching (86.4 vs.
82.3%, HR 1.33, 95%CI:1.05-1.7 and p¼0.01). Stenting was associated withacts/POSTER/STEMI/NSTEMI/ACS B81
